Analyst Ratings for BeOne Medicines (ONC)
ONC Rating Summary
ONC Price Target Summary
- Highest: $453.00 (Citi)
- Lowest: $250.00 (Aletheia Capital)
- Average: $385.93
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$385.93 (+42.9%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$385.93 (+42.9%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
415.00 (N/A) |
293.09 (270.15) |
-7.83% | Details |
| 3/26/2026 | Wolfe Research | Kalpit Patel | New Coverage | Outperform (N/A) |
340.00 (N/A) |
283.45 (270.15) |
-4.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
